ir.acorda.comAcorda Therapeutics Inc - Investors
ir.acorda.com Profile
Ir.acorda.com is a subdomain of acorda.com,
which was created on 1997-07-28,making it 27 years ago.
It has several subdomains, such as grants.acorda.com , among others.
Discover ir.acorda.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.acorda.com Information
| HomePage size: 112.214 KB |
| Page Load Time: 0.335175 Seconds |
| Website IP Address: 162.159.129.11 |
ir.acorda.com Similar Website
| Maryland Real Estate Investors Association - Maryland Real Estate Investors Association |
| Avenue Therapeutics, Inc. (ATXI) |
| Viridian Therapeutics, Inc. - Investors & Media |
| Western Midstream - Investors - Investors |
| Investors | Kidoz Inc. – Kidoz Inc. |
| OMNOVA Solutions - Investors - Investors |
| Investors | Marathon Oil Corporation - Investors |
| Axalta Coating Systems - Investors - Investors Overview |
| Investor Relations :: Checkpoint Therapeutics, Inc. (CKPT) |
| Investors | Horizon Therapeutics plc |
| Acorda Therapeutics Grant Application Portal |
| Investors | PTC Therapeutics, Inc. |
| Investors | Flexion Therapeutics, Inc. |
| Connected Investors | Connect With Real Estate Investors |
| Investors - Toromont Industries Ltd. - Investors |
ir.acorda.com PopUrls
| Investors: Acorda Therapeutics Inc https://ir.acorda.com/investors/default.aspx |
| Investors - Investor News - Acorda Therapeutics Inc https://ir.acorda.com/investors/investor-news/default.aspx |
| Stock Information - Investors - Acorda Therapeutics https://ir.acorda.com/investors/stock-information/ |
| Site Map - Investors - Acorda Therapeutics https://ir.acorda.com/site-map/default.aspx |
| Email Alerts - Acorda Therapeutics Inc https://ir.acorda.com/email-alertsa/default.aspx |
| Investors - Investor Events - Acorda Therapeutics Inc https://ir.acorda.com/investors/investor-events/default.aspx |
| Investors - Corporate Governance - Acorda Therapeutics Inc https://ir.acorda.com/investors/corporate-governance/default.aspx |
| Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset ... https://ir.acorda.com/investors/investor-news/investor-news-details/2024/Acorda-Therapeutics-and-Merz-Announce-Signing-of-Stalking-Horse-Asset-Purchas |
| Acorda Therapeutics Reports First Quarter 2021 Financial Results https://ir.acorda.com/investors/investor-news/investor-news-details/2021/Acorda-Therapeutics-Reports-First-Quarter-2021-Financial-Results/default.aspx |
| Annual Reports - Acorda Therapeutics Inc - Investors https://ir.acorda.com/investors/financial-information/annual-reports/default.aspx |
| Acorda Therapeutics Inc - Acorda Therapeutics Announces Agreement to ... https://ir.acorda.com/investors/investor-news/investor-news-details/2021/Acorda-Therapeutics-Announces-Agreement-to-Commercialize-INBRIJA-in-Spain/def |
| Acorda Therapeutics Reports Second Quarter 2021 Financial Results https://ir.acorda.com/investors/investor-news/investor-news-details/2021/Acorda-Therapeutics-Reports-Second-Quarter-2021-Financial-Results/default.asp |
| Acorda Therapeutics Reports Third Quarter 2021 Financial Results ... https://ir.acorda.com/investors/investor-news/investor-news-details/2021/Acorda-Therapeutics-Reports-Third-Quarter-2021-Financial-Results-Additions-to |
ir.acorda.com Httpheader
| Date: Tue, 14 May 2024 19:19:46 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 883d3de0c862ef7f-PDX |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Last-Modified: Tue, 14 May 2024 19:19:46 GMT |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-XSS-Protection: 0 |
| Server: cloudflare |
ir.acorda.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="LMfUKkmDdJlfV8rd6mlWvazUzYjZgGgxpxfMXfVcOjc" name="google-site-verification"/ |
ir.acorda.com Html To Plain Text
query Home About Acorda Company Leadership Management Team Board of Directors Grant Program Compliance Acorda Compliance Message From BIO Diversity and Inclusion Contact Us For Patients Focus On Therapies In the Community Resources Policy on Access to Unapproved Medicines Products & Research Pipeline ARCUS® Technology Products AMPYRA® (dalfampridine) INBRIJA™ (levodopa inhalation powder) Terms and Conditions (Product Purchases) Clinical Trials Terms and Conditions (Product Purchases) Investors Corporate Governance Stock Information Investor Events Investor News Financial Information Quarterly Updates Annual Reports SEC Filings Investor Resources Investor Kit E-mail Alerts FAQs IR Contact News & Events In the News Awards Press Releases Social Media Careers Working at Acorda Our Employees Benefits Job Openings Investors Our Mission Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. LEARN MORESearch query Home About Acorda Company Leadership Management Team Board of Directors Grant Program Compliance Acorda Compliance Message From BIO Diversity and Inclusion Contact Us For Patients Focus On Therapies In the Community Resources Policy on Access to Unapproved Medicines Products & Research Pipeline ARCUS® Technology Products AMPYRA® (dalfampridine) INBRIJA™ (levodopa inhalation powder) Terms and Conditions (Product Purchases) Clinical Trials Terms and Conditions (Product Purchases) Investors Corporate Governance Stock Information Investor Events Investor News Financial Information Quarterly Updates Annual Reports SEC Filings Investor Resources Investor Kit E-mail Alerts FAQs IR Contact News & Events In the News Awards Press Releases Social Media Careers Working at Acorda Our Employees Benefits Job Openings Privacy Policy Terms Of Use Site Map Contact Us Latest Latest NewsApril 15, 2024 Acorda Therapeutics Announces Delisting from Nasdaq Read More April 3, 2024 Acorda Therapeutics Announces Nasdaq Delisting Notification Read MoreView News Archives Latest Latest Events April 1, 2024 Acorda Provides Financial and Business Update for Fourth Quarter/Year End 2023 Listen to webcast View Press Release ? ( ) Read More November 13, 2023 Acorda Provides Financial and Business Update for Third Quarter 2023 Listen to webcast View Press Release ? ( ) Read More View More Events Quick Links View our investor kit MEET OUR LEADERSHIP TEAM Board Of Directors Contact Us SEC Filings Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At COMPANY NAME, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to COMPANY NAME to send you the requested Investor Email Alert updates. * Required Email Address * Mailing Lists * News Releases Alert SEC Alert Events Alert Calendar Alert Un-subscribe from email alerts Email Alert Sign Up Confirmation Text size A A A Email a friend Print ABOUT ACORDA Company Leadership Management Team Board of Directors Grant Program Compliance Acorda Compliance Message From BIO Diversity and Inclusion Contact Us FOR PATIENTS Focus On Therapies In The Community Resources Policy on Access to Unapproved or Uncommericalized Medicines PRODUCTS & RESEARCH ARCUS® Technology Products AMPYRA® (dalfampridine) INBRIJA® (levodopa inhalation powder) Terms and Conditions (Product Purchases) Clinical Trials INVESTORS Corporate Governance Stock Information Investors Events Investor News Financial Information Quarterly Reports Annual Reports SEC Filings Investor Resources Investor Kit E-mail Alerts FAQs IR Contact NEWS & EVENTS In The News Awards Investor News Social Media CAREERS Working At Acorda Our Employees Benefits Job Openings Home | Privacy Policy | Terms Of Use | Site Map | Contact Us © Copyright 2021 Powered By Q4 Inc....
ir.acorda.com Whois
Domain Name: ACORDA.COM Registry Domain ID: 2821055_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2024-02-26T05:58:22Z Creation Date: 1997-07-28T04:00:00Z Registry Expiry Date: 2024-07-27T04:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.CV.NET Name Server: DNS1.CVNET.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:31:02Z <<<